Athenex Announces Axis Therapeutics Has Entered into a MOU with the Hong Kong Polytechnic University to Set Up a Joint Research Center on Cancer Immunotherapy
July 18, 2018 09:00 ET
|
Athenex, Inc.
BUFFALO, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex Names Timothy Cook as Senior Vice President of Global Commercial Oncology
July 09, 2018 06:30 ET
|
Athenex, Inc.
Mr. Cook was Previously VP and Chief Operating Officer of Oncology at Lilly BUFFALO, N.Y., July 09, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company...
Athenex宣佈獲Perceptive Advisors策略投資1億美元用於在研藥物擴充計劃
July 03, 2018 10:28 ET
|
Athenex, Inc.
與Xiangxue Pharmaceutical聯合擴充TCR-T免疫療法的產品群組獲得Avalon BioMedical Management的生物產品引入授權 美國紐約州水牛城, July 03, 2018 (GLOBE NEWSWIRE) -- 致力於癌症及相關症狀治療新型療法的發現、研製和商業化的全球生物製藥公司Athenex,...
Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors
July 02, 2018 06:30 ET
|
Athenex, Inc.
Collaboration with Xiangxue Pharmaceutical Expands Portfolio in to TCR-T ImmunotherapyIn-Licensing of a Biologic Product from Avalon BioMedical Management BUFFALO, N.Y., July 02, 2018 (GLOBE...
Athenex宣布任命董事會成員
June 15, 2018 16:55 ET
|
Athenex, Inc.
紐約州水牛城, June 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (納斯達克:ATNX) 是一家致力於發現、開發以及將癌症及相關疾病新療法商業化的全球生物製藥公司。該公司今天宣布任命Benson Tsang為董事會成員，自2018年7月1日起生效。Tsang先生將擔任審計和風險管理委員會主席，以及提名和公司治理委員會成員。 ...
Athenex Announces Appointment to Board of Directors
June 15, 2018 07:00 ET
|
Athenex, Inc.
BUFFALO, N.Y., June 15, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex委任Christina Wang為亞太區臨床業務和企業發展副總裁
June 05, 2018 04:47 ET
|
Athenex, Inc.
紐約州水牛城, June 05, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX)，一家致力於發現、開發以及將治療癌症及相關疾病新型療法商業化的全球生物製藥公司，今天宣布委任Christina Wang為亞太區臨床業務和企業發展副總裁。 ...
Athenex在ASCO年會上發表展板陳述
June 05, 2018 04:37 ET
|
Athenex, Inc.
紐約州水牛城, June 05, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX)，一家致力於發現、開發以及將治療癌症及相關疾病新型療法商業化的全球生物製藥公司，今天宣布兩份關於Oraxol的展板陳述將於2018年6月1日至5日在芝加哥伊利諾伊州舉行的美國臨床腫瘤學會(ASCO)會議上發表。 ...
Athenex Names Christina Wang as Vice President of Clinical Operations and Corporate Development, Asia Pacific
June 04, 2018 08:00 ET
|
Athenex, Inc.
BUFFALO, N.Y., June 04, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex Announces Poster Presentations at ASCO Annual Meeting
June 04, 2018 07:00 ET
|
Athenex, Inc.
BUFFALO, N.Y., June 04, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...